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ABSTRACT
Oligonucleotide microarrays have been applied to
microbial surveillance and discovery where highly
multiplexed assays are required to address a wide
range of genetic targets. Although printing density
continues to increase, the design of comprehensive
microbial probe sets remains a daunting challenge,
particularly in virology where rapid sequence evolu-
tion and database expansion confound static solu-
tions. Here, we present a strategy for probe design
based on protein sequences that is responsive to
the unique problems posed in virus detection and
discovery. The method uses the Protein Families
database (Pfam) and motif finding algorithms to
identify oligonucleotide probes in conserved amino
acid regions and untranslated sequences. In silico
testing using an experimentally derived thermody-
namic model indicated near complete coverage of
the viral sequence database.
INTRODUCTION
The capacity of DNA microarrays to simultaneously
screen for hundreds of viral agents makes them an
attractive supplement to traditional methods in micro-
biology. Their utility has been demonstrated through
detection of papilloma virus in cervical lesions (1), SARS
coronavirus in tissue culture (2), parainﬂuenza virus 4 in
nasopharyngeal aspirates (3), inﬂuenza from nasal wash
and throat swabs (4,5), gammaretrovirus in prostate
tumors (6), coronaviruses and rhinoviruses from nasal
lavage (7), metapneumovirus from bronchoalveolar lavage
(8), ﬁloviruses and malarial parasites in blood in hemor-
rhagic fever (9), and a wide variety of respiratory
pathogens in nasal swabs and lung tissue (10).
Viral microarrays have increased in density and strain
coverage as fabrication technologies have improved.
cDNA pathogen arrays derived from reference strain
nucleic acids (11,12) have been replaced by oligonucleotide
arrays due to their increased ﬂexibility. Oligonucleotide
design strategies have focused on pairwise sequence
comparisons to identify conserved regions within a variety
of viral pathogens (13–15). Multiple alignments have been
used to design probes for clinically important virus genera,
e.g. rotaviruses (16), orthopoxviruses (17) or inﬂuenza-
viruses (18). Viral resequencing arrays have recently been
introduced thatallow single nucleotide resolution (4,19–21).
Although such tiling arrays enable accurate typing, the
number of probes required to build a resequencing array
for all viral sequences exceeds current art.
A comprehensive viral microarray should address the
entire viral sequence database. Pairwise nucleic acid
comparisons, while rapid, do not scale well with sequence
number and ignore valuable coding information. Non-
overlapping segments, heterogeneous sizes and the large
number of sequences preclude automated multiple align-
ments of nucleic acids for probe design. Protein–protein
comparisons are more sensitive for detecting conserved
regions due to the power of substitution matrices (22);
however, at the time of writing, no reported oligonucleo-
tide design algorithm leverages this information.
The Protein Families Database (Pfam) (23) is a
repository of hand curated protein multiple alignments
and Hidden Markov Models (HMMs) across all phyloge-
netic kingdoms. HMMs are probabilistic representations
of protein alignments that are well suited to identifying
homologies (24,25). Beginning with the Pfam database as a
foundation, we established a tiered method for creating
viral probes that uses all sequence information available
for viruses. Our method for probe design employs protein
alignment information, discovered protein motifs, nucleic
acid motifs and ﬁnally, sliding windows to ensure near
complete coverage of the database.
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Exploratory arraydesign and hybridization
We pursued experiments to determine the eﬀects of probe-
target mismatch and background nucleic acid concentra-
tion on array sensitivity and speciﬁcity; results were used to
derive parameters for probe design. West Nile virus RNA
(WNV, strain New York 1999, AF202541) was used as
template in hybridization experiments on an Agilent
oligonucleotide array with 1131 complementary probes
of length 60 nucleotides (nt). Approximately one third of
the probes had between 1 and 20 randomly introduced
mismatches. The plus and minus (reverse complement)
strands of each sequence were deposited, in duplicate. In
addition to the ﬂaviviral speciﬁc probes, the array
contained nearly 36500 probes for other viral families,
negative and positive controls. A volume containing 10
6
copies of WNV and 200ng of background nucleic acid
(human lung tissue RNA) was ampliﬁed using random
primers and hybridized in four replicate experiments as
previously described (10).
Analysisof impact of probe-template mismatches on
fluorescence
Hybridizing a WNV isolate of known sequence allowed
prediction of probe-viral hybrid strength and correlation
to ﬂuorescence data. To predict hybrids with high accu-
racy, Smith–Waterman alignments of the virus sequence
against microarray probes were generated using the
EMBOSS bioinformatics suite (26). The number of mis-
matches was calculated for each expected probe-target
pair. The change in Gibbs free energy at 658C (hybridiza-
tion temperature) was calculated using PairFold version
1.7 (27) as a separate measure of probe-template binding
strength. PairFold employs a dynamic programming
algorithm to compute the minimum free energy structure
(excluding pseudo-knots); the standard free energy model
is used (28) with empirical nearest neighbor energies (29).
The arrays were visualized with an Agilent slide scanner,
then processed with the quantile normalization technique
(30). SPSS version 14 was used for statistics and data plots
(http://www.spss.com/), ﬂuorescence data is available as
supplementary material.
Viral sequence database
The EMBL nucleotide sequence database [July 2007,
Release 91; 461,353 nucleic acid sequences (31)] was
chosen as the reference for this study because it is tightly
integrated with the Pfam protein family database (23,32).
We incorporated all viral genomes in the NCBI Reference
Sequence (RefSeq) project on 21 May 2007 (1701 unique
viruses; 2790 genome segments). EMBL Release 91
included 183924 HIV-1 sequences (39.8% of the database,
classiﬁed by NCBI Taxid 11676). Of these, 151 878 HIV-1
sequences were  1kb, (median length 440nt). To simplify
computation, we selected only those 1915 HIV-1 sequences
>7000nt in length (full genome is 9200nt). The ﬁnal
dataset contained 281632 nucleic acid sequences.
Taxon growth was estimated using a standard
least squares method, with the SPSS statistical package.
A non-redundant database comprising 74044 sequences
was generated with CD-Hit (33), using a similarity cutoﬀ
of 98% to deﬁne sequences as identical. Bacteriophages
were not included in the analysis; however, data were
retained to allow probe design using the EMBL phage
database.
Extraction of conserved regionsand nucleic acidsequence
from Pfam-A alignments
The Pfam database is comprised of hand curated seed
protein alignments that are converted to a probabilistic
representation using HMMs. These HMMs are used to
search the protein database for homologues that can be
added to the seed to create a comprehensive alignment
(23,24). Pfam domains were analyzed to identify short,
conserved protein regions and corresponding nucleic acid
sequences. In the ﬁrst step, the log-odds score for each
position of the HMM built from the seed alignment was
summed; lower scores were considered to indicate
conservancy. The most conserved, non-overlapping 20
amino acid (aa) regions were identiﬁed. In the second step,
protein alignments of all Pfam-A families were extracted
and mapped to their underlying nucleotide sequences by
cross reference to the EMBL records. HMM parsing
modules from the BioPerl package were used. In the third
step, the underlying nucleotide sequences were extracted
and stored. In cases where the region contained gaps,
ﬂanking nucleotides were brought together to yield
sequences of length 60. These sequences formed the
basis for downstream probe design. Domain alignments
in the Pfam-B were not used in probe design because they
are of lower quality; also, as domain quality improves
these alignments will be integrated into Pfam-A (23).
Motif findingfor non-Pfam coding sequences
All coding nucleic acid sequences that were not part of
a Pfam-A alignment were extracted. In this step, the most
conserved regions within homologous genes were identi-
ﬁed for probe design. Sequences were clustered at the
protein level with CD-Hit, using a similarity threshold of
80%. All sequence clusters were subjected to a MEME
motif search (34) using the following parameters: motif
width of 20, zero or one motif allowed per sequence, a
minimum of two sequences per motif. Three motifs were
selected for each sequence cluster. The underlying nucleic
acid sequence extracted for each protein motif was used
for probe design.
A sliding window approach was used for highly
divergent sequences that did not share any motifs. Using
the PAM250 matrix (35) a summed log odds scores for
every 20 aa subsequence in the protein was calculated; the
three least likely to vary (lowest log odds score) were
selected as regions for probe design.
Motif findingfor non-coding regionsand
unannotated sequences
Viruses often have highly conserved non-coding regions at
the termini of their genomes or genome segments that
serve critical roles in replication, transcription, and
packaging. We reasoned that probes based in these
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conserved probes across homologous regions in sequences
annotated as 50 UTR, 30 UTR, LTR, and those without
annotation. Sequences were ﬁrst clustered at the 80%
threshold. Clustered sequences were then subjected to a
motif search using the same parameters employed for
proteins, except that a length of 60nt per motif was
speciﬁed. We addressed sequences that did not contain a
shared motif separately; three non-overlapping 60nt sub-
sequences were chosen as probes.
Probe selection andminimization withset coveralgorithm
An algorithm was designed to automate identiﬁcation of
the minimum set of probes required to address a repertoire
of potential viral targets (36). In the ﬁrst step of analysis,
the number of mismatches between a probe and its viral
target was computed; the algorithm considered a probe to
be ‘covering’ if it had  5 mismatches to the template.
Coverage data were converted to a matrix of binary
values. A greedy algorithm was implemented to choose a
probe combination from the matrix, minimizing the
number required probes. Candidate probes were further
screened to ensure a Tm >608C, no repeats exceeding a
length of 10nt, no hairpins with stem lengths exceeding
11nt, and <33% overall sequence identity to non-viral
genomes.
Analysis ofcoverage by Gibbs free energy
Because it is not feasible to test all probes with all known
viruses, we tested probe validity using a Gibbs free energy
model of hybridization. All probe sequences were
compared to the non-redundant set of viral sequences by
BLASTN (37). Probe-target pairs were aligned by Smith–
Waterman to ensure accuracy; mismatches and change in
Gibbs free energy at 658C (hybridization temperature)
were then calculated.
Design ofviral genome tiling probes
To gauge the performance of our probe selection
algorithm, another comprehensive method was devised
that used only nucleic acid sequence. Sequences in the
Reference Sequence Viral Genomes project (38) are evenly
distributed among viral families; therefore, we reasoned
that probes derived from these sequences would provide
broad coverage. To contrast with our method, we selected
60nt oligonucleotides end-to-end along all viral genomic
RefSeq sequences (1701 viruses). This resulted in a tiling
probe-set where the length of a sequence was proportional
to the number of interrogating probes.
RESULTS
The viral sequence database isdominated by gene fragments
Sequence information has grown rapidly since the advent
of modern capillary sequencing techniques; 461 353 viral
sequences are currently available [EMBL release 91 (31)].
Research into human pathogens has driven database
growth, as indicated by the high number of retroviral (204
668, 44%), ﬂaviviral (71 531, 16%) and orthomyxoviral
(47 248, 10%) sequences. The high number of retroviral
sequences reﬂects the importance of HIV-1 gag and
pol gene sequences in clinical management of HIV
infection (39).
We queried the EMBL viral database to determine
the frequencies of coding sequences and full genomic
sequences. The majority of viral sequences were <1kb
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Figure 1. Characteristics of the viral database. (a) Distribution of viral
sequence length in EMBL nucleotide database July 2007, all sequence
 5kb were grouped together. (b) Growth of sequence diversity over
time in the HIV-1 ﬁltered database; unique sequences were identiﬁed by
sequence clustering the 98% similarity level. (c) Growth of taxonomic
classes over time; linear regression was used to project growth from
year 2006 to 2010.
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(385 951, 83.7%) were annotated as coding for a
single gene; 7.2% coded for two or more genes. Of all
coding sequences,  80% (306933, 79.5%) were annotated
as partial gene sequences (EMBL Release 91, July 2007).
As of May 2007, the Reference Sequence Viral Genomes
project (38) has catalogued 1701 viral strain representa-
tives (2790 total genome segments). Overall, 1.6% (7662)
of viral sequences are annotated as complete genomes.
Of the 275 known viral genera, nearly all had at least
one complete genomic sequence. All genera containing
vertebrate pathogens had at least one fully sequenced
genome.
The viralsequence database oversamples HIV-1 and is
highlyredundant
HIV-1 sequences represent 44% of the current EMBL
viral database; 83% of these sequences are less than 1 kb
in length. A viral microarray that mirrored the database
would oversample HIV and undersample other viruses.
Thus, we elected use only the near complete genome
sequences of HIV-1, for which exist representatives of
each known group and subtype (40). The ﬁltered sequence
database comprising 281 632 sequences was generated
from EMBL Release 91 by excluding HIV-1 sequences
<7000nt in length. This ﬁltered database was subse-
quently used for probe design.
A commonly used method to reduce sequence complex-
ity is generation of a non-redundant sequence set by
clustering (33). We grouped sequences at the 98% identity
level and selected the longest sequences as unique
representatives of each group. This method was used to
assess the growth of sequence diversity between January
2000 and the current release of July 2007. The database
grew 600% in the 7-year period; doubling every three
years. Unique sequences decreased as a proportion of the
database, from 42% to 27%; overall growth of unique
sequences was 378% (Figure 1b). The current database
comprised 74 044 unique sequence representatives at the
98% similarity level. Thus, the growth in the number of
sequences in the viral database has been rapid, while
growth in diversity has been more modest.
One hypothesis to explain this slower growth of
sequence diversity is that many of the existing viruses
infecting humans have already been discovered and new
isolates deposited are variants of well studied viruses. We
charted the growth of viral taxonomic groups as a
function of time to visualize trends in viral discovery
(Figure 1c). The number of families and genera has
remained stable since 1996; however, the number of
sequences that have been classiﬁed as a new species has
steadily risen. A least squares ﬁt of this growth indicates
that the steady increase in new species characterization is
likely to continue, while the discovery of new viral families
will be less common.
Atiered, protein-motif-based approach to probedesign
addresses all viral sequences
Nucleotide sequences were divided into four subtypes:
(i) coding sequences that corresponded to Pfam-A
alignments (cPf), (ii) coding sequences not in the Pfam-A
(cNPf), (iii) sequences that were annotated as untrans-
lated regions (UTR) or long terminal repeats (LTR) and
(iv) sequences that were unannotated (UA). We sought
to match the quality of Pfam-A alignments in the non-
Pfam coding sequences by clustering them into groups of
related sequences, approximating homologous genes.
These were then subjected to a protein motif ﬁnding
program to identify the conserved regions within each
cluster. The untranslated and unannotated sequences
were subjected to a similar clustering analysis, but at the
nucleotide level.
All four subtypes were subjected to the same three step
design method: identiﬁcation of conserved regions,
extraction of nucleotide probe sequences, and minimiza-
tion of covering probes. By allowing a limited number of
mismatches to cognate templates, the number of probes
required can be reduced. The mismatch threshold was
determined based on experiments with West Nile virus
(strain New York 1999, AF202541) that indicated high,
homogenous ﬂuorescence signal was observed if probes
had ﬁve or fewer mismatches to the viral template
(Figure 2). The probe minimization technique serves to
lower microarray printing costs and simplify analysis
while maintaining sequence coverage. A ﬂowchart of the
design method is depicted in Figure 3.
The most recent Pfam-A release (Version 22) comprised
9318 families, of which 1540 had viral members. Of 405
543 annotated protein sequences with length >20 aa, 278
119 (68.6%) belonged to a Pfam-A family, while 127 424
(31.4%) did not. Three probes were chosen for each gene,
yielding a total of 104 467 cPf and 133 513 cNPf probes.
Of sequences not contained in Pfam-A, only 5.6% (6956)
were found in Pfam-B alignments. Thus, due to the lower
quality of alignments (23) and poor viral representation,
the Pfam-B was not used for probe design. The 12 428
untranslated regions processed yielded 4616 probes.
For the 24 841 unannotated sequences processed, 13 740
probes were designed. Sequences that were not covered
due to high/low GC%, low complexity, repetitive
sequence or a preponderance of ambiguous nucleotides
(4244) were processed with a sliding window strategy; 14
530 probes were designed. Overall, the number of probes
required to address all viral sequences was 270 866.
Sequence counts and probe counts for the most recent
EMBL/Pfam release are detailed in Figure 4. An example
of typical probe distribution is shown with respect to the
Dengue virus 1 genome (NC_001477; Figure 5).
Validation of probes by predicted affinity totargets
Probe sequence composition is a major determinant of
hybridization signal and is responsible for much of the
variance between probes that target the same nucleic acid
strand. Probe-target thermodynamics have been success-
fully modeled to predict ﬂuorescence (41,42), control for
variance (43) and even estimate concentrations of target
detected in samples (44). Observing that some probes with
more than ﬁve mismatches to their targets showed
strong ﬂuorescent signal, we concluded that sequence
composition is a major factor in our array platform.
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generating a simple thermodynamic model to predict
hybridization signal based on sequence composition. We
computed the change in Gibbs free energy (G) for all
expected probe-viral nucleic acid pairs in the West Nile
virus hybridization experiments described above.
The calculation method employed ﬁnds the most
thermodynamically stable structure (minimum free
energy) (28) based on empirically established nearest
neighbor energies (29). Strong signal was observed from
probe-virus hybrids with G of  32.5kJ or less. Thus,
this value was chosen as the threshold to classify a probe
as likely to generate high signal when the cognate viral
target is present (Figure 6).
Figure 2. Impact of mismatches on ﬂuorescence signal in microarray hybridization. West Nile virus (New York 1999 strain RNA) at 10
6 copies was
spiked into 200 ng of human lung (background) RNA. Total nucleic acid was ampliﬁed, labeled and hybridized. After normalization of replicate
arrays, log2 ﬂuorescence was converted to Z-Scores. 95% conﬁdence intervals of the mean for probes with the same number of mismatches were
plotted. Dotted line indicates maximum number of mismatches yielding an acceptable ﬂuorescence signal.
Non-Redundant
Viral Database
EMBL Viral DB
Cluster nucleic
acid sequences
at 98% identity
Protein Coding
Sequences
Sequences in a 
Pfam-A Family
Sequences not in a 
Pfam-A Family
Non Coding
UTRs& LTRs
Unannotated
Find short
motifs
MEME
Extract conserved 
regions from Pfam
alignment
MEME
MEME
Find
homologues
 
Cluster protein 
sequences
at 80% Identity
Sequences from Pfam
domain are the 
homologues
Cluster nucleic acid
sequences
at 80% Identity
 
Cluster nucleic acid
sequences 
at 80% Identity
Check probe for Tm, 
GC% and hairpins
Minimize needed 
probes with Set Cover 
solver
Make probes Verify
probe-set
coverage
1. Compare 
probes to non-
redundant
sequence 
database
2. Find sequences
that are not 
covered
 
3. Design sliding 
window probes
Find underlying nucleic
acid sequence
 
Homologous genes 
are likely to be have 
similar nucleic acid 
sequences
Probes will be
designed in the 
area of short 
motifs of 20aa or
60nt
 
 
Figure 3. Comprehensive motif-based probe design. The EMBL viral database is clustered with a threshold of 98% nucleotide identity to create a
non-redundant sequence database. Coding sequences are subjected to an amino acid motif search, and then probes are made from the underlying
nucleic acid sequences. Similarly, nucleic acid motifs are found in non-coding sequences and used to make probes. Database coverage is checked;
supplementary probes for highly divergent sequences are designed as necessary. Acronyms: Pfam—Protein Families database, MEME—Multiple
Expectation maximization for Motif Elicitation, UTR—untranslated region, LTR—long terminal repeat.
PAGE 5 OF 10 Nucleic Acids Research, 2008, Vol. 36,No. 1 e3Motif-based probedesign provides higher coverage than
virus genome tiling
Use of motif ﬁnding and set cover minimization markedly
increases the computational resources needed to generate
probe sets. To determine whether increased complexity
results in a more comprehensive probe set, we compared
our method to a genome tiling strategy. Probes of 60nt
were designed end-to-end along the entire genome for all
1701 Reference Sequence viral strains available as of May
2007. The tiling probe set served as a contrast to our
design method since it was based on nucleic acid sequence,
had more probes per gene, required less computation, and
included viruses from all genera.
In comparison of the methods, the following rules were
used to compute database coverage: sequences >400nt in
length were considered covered if six or more probes
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were considered covered if two probes met hybridization
criteria; sequences <200nt in length were considered
covered with a single probe meeting hybridization
criteria. Coverage of the entire database was gauged by
computing probe-template G for all 74044 unique
sequence representatives. Database coverage using the
tiling method was 47.8% and required 850136 probes;
coverage using the motif-based method was 99.7% and
required 270866 probes (Table 1).
Whereas probe design in motif-based arrays can exploit
partial genome sequences, probes in tiling arrays are based
on full length genome sequences. Complete Reference
Sequence genomes represent 1% of EMBL sequence
entries. Although at least one full length genome sequence
is described for all viral genera, only 49% (1701 of 3441)
of viral species have a fully sequenced representative
genome. The impact of diﬀerences in the motif and tiling-
based strategies for probe design is reﬂected in diﬀerences
in coverage. For the tiling-based probe-set, 40 of 44
families with <80% sequence coverage included species
lacking representative genomes. Coverage with motif-
based probe-sets for these same species was  93%.
DISCUSSION
Application of motif-based probedesign to viral
surveillance andgenomics
There is an increasing appreciation for the power of
microarray technology in clinical microbiology, public
health and environmental surveillance. Viral microarray
probe design poses unique challenges due to the rapid
increase in sequence data and the high propensity for
sequence divergence within viral taxa. To ensure coverage
of the newest isolates it is essential to consider partial as
well as complete genomic sequences in probe design.
Probe design based on multiple alignments or pairwise
comparisons of nucleic acids for all known sequences is
computationally intensive and scales poorly with database
size. Protein sequence comparisons are rapid and incor-
porate rich evolutionary models, but require a cumber-
some mapping step to extract underlying nucleic acid
sequence. We have described a method that capitalizes on
the Pfam protein alignment database and a motif ﬁnding
algorithm to automate the extraction of nucleic acid
sequence for probes from conserved protein regions.
The protein motif-centric method has several advantages:
(i) the majority of viral nucleic acid sequences encode
proteins; thus, using this information leverages knowledge
about function; (ii) protein sequence comparison and the
resulting probesets are independent of viral taxonomy;
this may enable incorporation of misclassiﬁed sequences;
(iii) the Pfam is a well established and highly annotated
database that will provide a basis for future design eﬀorts;
and (iv) probes designed in conserved regions may be able
to detect novel viruses.
Application toviral transcript profiling
A second application of this design method is viral
expression proﬁling. Insights into the replication cycle,
host evasion and virulence factors may be obtained by
monitoring viral transcript levels during infection. To this
end, arrays could be synthesized that combine probes for a
single viral family and all host genes. Because the viral
probe sets generated by our method account for known
variants across all genes, a variety of strains could be
proﬁled with a single array. This would provide a unique
experimental platform for investigating virus biology,
while minimizing fabrication cost and simplifying analysis.
Probeselection for other assayplatforms
The thresholds used to design and validate probes were
experimentally determined for the Agilent Technologies
array platform and the types of clinical samples our
Figure 6. Gibbs free energy model of hybridization signal. The change in Gibbs free energy of probe-West Nile virus hybrids was computed. Aliquots
of West Nile virus (New York 1999 strain RNA) at 10
6 copies were spiked into 200ng of human lung (background) RNA. The ﬂuorescent signal
values of replicate arrays were log2 transformed, normalized, and converted to Z-scores. 95% conﬁdence intervals of the mean for ﬂuorescence versus
Gibbs energy is plotted. Probe-virus hybrids with free energy  –32.5kJ had high ﬂuorescence; this value was chosen as the threshold for considering
a probe likely to generate a strong signal when the target virus is present (dotted line).
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Virus family Total sequences Full genome
sequences
Motif-based Tiling-based
Covered
sequences
Percentage Covered
sequences
Percentage
Adenoviridae 385 43 385 100.0 255 66.2
Arenaviridae 263 26 262 99.6 137 52.1
Arteriviridae 1891 4 1891 100.0 1328 70.2
Ascoviridae 38 3 38 100.0 26 68.4
Asfarviridae 92 1 86 93.5 64 69.6
Astroviridae 312 6 312 100.0 168 53.8
Avsunviroidae 124 4 124 100.0 122 98.4
Baculoviridae 414 40 408 98.6 249 60.1
Barnaviridae 1 1 1 100.0 1 100.0
Bicaudaviridae 2 2 2 100.0 2 100.0
Birnaviridae 284 12 284 100.0 255 89.8
Bornaviridae 22 1 22 100.0 22 100.0
Bromoviridae 475 72 472 99.4 409 86.1
Bunyaviridae 1204 66 1197 99.4 623 51.7
Caliciviridae 1644 16 1643 99.9 311 18.9
Caulimoviridae 227 27 224 98.7 95 41.9
Chrysoviridae 28 8 28 100.0 8 28.6
Circoviridae 174 16 174 100.0 170 97.7
Closteroviridae 386 27 386 100.0 240 62.2
Comoviridae 339 36 337 99.4 249 73.5
Coronaviridae 1040 18 1029 98.9 537 51.6
Corticoviridae 1 1 1 100.0 1 100.0
Cystoviridae 12 12 12 100.0 12 100.0
Dicistroviridae 67 14 67 100.0 54 80.6
Filoviridae 19 4 19 100.0 17 89.5
Flaviviridae 22034 42 22016 99.9 6105 27.7
Flexiviridae 916 61 910 99.3 464 50.7
Fuselloviridae 7 4 7 100.0 7 100.0
Geminiviridae 1406 236 1404 99.9 1353 96.2
Globuloviridae 3 2 3 100.0 3 100.0
Hepadnaviridae 2427 10 2427 100.0 2203 90.8
Hepeviridae 754 1 754 100.0 149 19.8
Herpesviridae 2164 47 2122 98.1 1147 53.0
Hypoviridae 34 4 34 100.0 21 61.8
Inoviridae 23 23 23 100.0 23 100.0
Iridoviridae 104 8 103 99.0 61 58.7
Leviviridae 9 9 9 100.0 9 100.0
Lipothrixviridae 5 2 5 100.0 2 40.0
Luteoviridae 172 18 172 100.0 154 89.5
Marnaviridae 1 1 1 100.0 1 100.0
Microviridae 42 42 42 100.0 42 100.0
Myoviridae 69 63 69 100.0 65 94.2
Nanoviridae 127 36 127 100.0 114 89.8
Narnaviridae 20 8 20 100.0 11 55.0
Nimaviridae 13 1 13 100.0 12 92.3
Nodaviridae 57 18 57 100.0 50 87.7
Orthomyxoviridae 4596 69 4589 99.8 3639 79.2
Papillomaviridae 803 60 792 98.6 248 30.9
Paramyxoviridae 1813 31 1807 99.7 1334 73.6
Partitiviridae 66 36 66 100.0 35 53.0
Parvoviridae 286 45 286 100.0 224 78.3
Phycodnaviridae 336 5 336 100.0 246 73.2
Picornaviridae 6672 35 6666 99.9 1792 26.9
Plasmaviridae 1 1 1 100.0 1 100.0
Podoviridae 70 52 70 100.0 53 75.7
Polydnaviridae 400 230 398 99.5 284 71.0
Polyomaviridae 353 14 353 100.0 187 53.0
Pospiviroidae 156 25 156 100.0 147 94.2
Potyviridae 1828 64 1827 99.9 1385 75.8
Poxviridae 364 24 342 94.0 242 66.5
Reoviridae 2717 363 2694 99.2 908 33.4
Retroviridae 7795 54 7789 99.9 4335 55.6
Rhabdoviridae 1334 19 1331 99.8 588 44.1
Roniviridae 7 0 7 100.0 0 0.0
Rudiviridae 13 3 12 92.3 6 46.2
(continued)
e3 Nucleic Acids Research, 2008, Vol. 36,No. 1 PAGE8 OF10laboratory encounters. Probe length can be selected to
emphasize eﬃcient coverage of higher order taxa or
speciation. The goal of this project is to cover all known
viral sequences and optimize potential for detecting
related viral sequences. Thus, we designed 60nt probes
because they can better tolerate mismatched templates
than 25nt oligonucleotide probes (45). Using an empirical
approach, appropriate thresholds can be determined for
other array platforms, hybridization conditions, and
probe lengths. The method of probe design and set-
cover minimization is ﬂexible and agnostic of platform;
application to bead, solution, or surface-based hybridiza-
tion technology should be straightforward.
Importance of continuous updates
Although the growth of the public sequence databases has
been rapid, sequence diversity has not grown as quickly.
If this trend continues, we anticipate that only incremental
updates to a core set of probes will be needed to maintain
array integrity. An update strategy would require periodic
testing of probe sets against newly deposited sequences
and fresh design only in the cases of high sequence
divergence.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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